RISK OF ADENOCARCINOMA IN BARRETT'S ESOPHAGUS

被引：0
|
作者：
Serha, T., V [1 ]
Kuryk, O. H. [2 ]
Yakovenko, V. O. [3 ]
Tkachenko, R. P. [2 ]
机构：
[1] Bogomolets Natl Med Univ, Kiev, Ukraine
[2] SI Res & Pract Ctr Prevent & Clin Med, State Adm Dept, Kiev, Ukraine
[3] Oberih Clin, Med Ctr, Kiev, Ukraine
来源：
WORLD OF MEDICINE AND BIOLOGY | 2020年 / 71卷 / 01期
关键词：
Barrett's esophagus; metaplasia; dysplasia; esophageal adenocarcinoma; POPULATION; PROGRESSION; MANAGEMENT; MORTALITY; DIAGNOSIS;
D O I：
10.26724/2079-8334-2020-1-71-120-124
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The total of 7396 videoesophagogastroscom cases were analyzed. The presence of metaplastic columnar epithelium of esophagus was found in 2910 patients (39.4"0) at pathohistological examination. The gastric metaplasia was evaluated in 876 cases (11.9%), the specialized intestinal metaplasia without dysplasia - in 1970 (26.6%), the low-grade dysplasia - in 48 (0.65%), the high-grade dysplasia - in 16 (0.22%). Esophageal adenocarcinoma was evaluated in four patients (0.05%, CI 0.01 - 0.12%). Low probability of esophageal adenocarcinoma formation in all types of metaplasia was demonstrated. Only the presence of dysplasia of metaplastic epithelium should cause increased alertness for the occurrence of esophageal adenocarcinoma. Exaggerated value of Barrett's esophagus may result in additional traumatization of mucosa, increase the risk of bleeding and stenosis.
引用
收藏
页码：120 / 124
页数：6
相关论文
共 50 条
  • [1] Barrett's esophagus - Reducing the risk of progression to adenocarcinoma
    Reynolds, JC
    Waronker, M
    Pacquing, MS
    Yassin, RR
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1999, 28 (04) : 917 - +
  • [2] Determination of risk for Barrett's esophagus and esophageal adenocarcinoma
    Thrift, Aaron P.
    [J]. CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (04) : 319 - 324
  • [3] Adenocarcinoma in Barrett's Esophagus
    Barret, Maximilien
    Chaussade, Stanislas
    Coriat, Romain
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (26): : 2539 - 2539
  • [4] Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population
    Ibiebele, Torukiri I.
    Hughes, Maria Celia
    Nagle, Christina M.
    Bain, Christopher J.
    Whiteman, David C.
    Webb, Penelope M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (01) : 214 - 224
  • [5] Alcohol Drinking and the Risk of Barrett's Esophagus and Esophageal Adenocarcinoma
    El-Serag, Hashem B.
    Lagergren, Jesper
    [J]. GASTROENTEROLOGY, 2009, 136 (04) : 1155 - 1157
  • [6] Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma
    Wong, A
    Fitzgerald, RC
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (01) : 1 - 10
  • [7] Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus
    Gatenby, Piers
    Caygill, Christine
    Wall, Christine
    Bhatacharjee, Santanu
    Ramus, James
    Watson, Anthony
    Winslet, Marc
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (28) : 9611 - 9617
  • [8] Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma
    Avidan, B
    Sonnenberg, A
    Schnell, TG
    Sontag, SJ
    [J]. GASTROENTEROLOGY, 2001, 121 (06) : 1281 - 1285
  • [9] Barrett's esophagus and risk of esophageal adenocarcinoma: A retrospective analysis
    Wang, Hung-Wei
    Kuo, Chia-Jung
    Lin, Wey-Ran
    Hsu, Chen-Ming
    Ho, Yu-Pin
    Lin, Chun-Jung
    Chen, Kuang-Hua
    Su, Ming-Yao
    Chiu, Cheng-Tang
    [J]. ADVANCES IN DIGESTIVE MEDICINE, 2015, 2 (04) : 135 - 140
  • [10] Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus
    Piers Gatenby
    Christine Caygill
    Christine Wall
    Santanu Bhatacharjee
    James Ramus
    Anthony Watson
    Marc Winslet
    [J]. World Journal of Gastroenterology, 2014, (28) : 9611 - 9617
12345